Latest stories on ERAS
Important Notice Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Power Solutions International, Inc. (NASDAQ: PSIX); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your Behalf
GlobeNewswire34 · bearishgeneral
Erasca draws shareholder scrutiny after ERAS-0015 comparisons and IP risk allegations
October 20, 2026
MarketChameleon34 · bearishgeneral
Erasca Terminating Employment of Chief Operating Officer Nicholas Chetwyn on Nov. 2 >ERAS
MarketWatch34 · bearishgeneral
Erasca drops after sacking COO
Seeking Alpha34 · bearishgeneral
Erasca realigns leadership to focus RAS oncology programs
TipRanks54 · neutralproduct/pr
Erasca, Inc. (ERAS) files 8-K
SEC 8-K50 · neutralgeneral
Erasca, Inc.: The Discount RevMed?
Seeking Alpha63 · neutralanalyst
Erasca participates in a conference call with JPMorgan
The Fly55 · neutralgeneral
Erasca: Revolution's Approval Just Took Risk Out Of The Fast Follower
Seeking Alpha63 · neutralgeneral
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
Business Insider63 · neutralproduct/pr
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
GlobeNewswire63 · neutralproduct/pr
Long-Term Shareholders of Erasca, Inc. (ERAS) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims
GlobeNewswire50 · neutralgeneral
Erasca, Inc. (ERAS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral